SCHEMBL2505002

SCHEMBL2505002

Cc1ccccc1N(c1cccc(O)c1)c1ccccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
TSHR P16473 1/20 0.53
CYP3A4 P08684 2/20 0.48
ACHE P22303 1/20 0.43
HSD17B1 P14061 5/20 0.43
HSD17B2 P37059 5/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA12 O43570 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
MEN1 O00255 1/20 0.37
HSP90AA1 P07900 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8944292 0.88 TSHR (0.39) ALDH1A1TSHRCYP3A4ACHECYP1A2
SCHEMBL11569334 0.85 ALDH1A1 (0.55) ALDH1A1TSHRCYP3A4ACHEHSD17B1
SCHEMBL19439765 0.84 ESR2 (0.44) ALDH1A1TSHRCYP3A4HSD17B1HSD17B2
SCHEMBL18610740 0.83 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4ACHEHSD17B1
SCHEMBL21173774 0.82 ACHE (0.42) ALDH1A1CYP3A4ACHEHSD17B1HSD17B2
SCHEMBL16378505 0.81 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4ACHEHSD17B1
SCHEMBL15553940 0.79 ALDH1A1 (0.42) ALDH1A1TSHRACHELMNAKMT2A
SCHEMBL29007292 0.79 CYP3A4 (0.39) ALDH1A1CYP3A4CYP1A2CYP2C19LMNA
SCHEMBL312994 0.79 ACHE (0.43) ALDH1A1TSHRCYP3A4ACHECYP1A2
SCHEMBL29372483 0.79 ACHE (0.43) ALDH1A1TSHRCYP3A4ACHECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120189347-A1 CHARGE TRANSPORT MOLECULES AND METHOD FOR PREPARING SAME XEROX CORPORATION 2012-07-26 US disclosed
US-20110245541-A1 Charge Transport Molecules And Method For Preparing Same XEROX CORPORATION (US) 2011-10-06 US disclosed
US-3965087-A Trisazo dye containing a diphenylenesulfone structure SAKAI CHEMICAL INDUSTRY COMPANY LTD. (JA) 1976-06-22 US disclosed
US-3951941-A POLYAZODYE SAKAI CHEMICAL INDUSTRY COMPANY, LIMITED (JA) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245541-A1 Charge Transport Molecules And Method For Preparing Same SLC43A1, HRH3, H1-4 ALDH1A1 1657/4885TSHR 201/4885CYP3A4 253/4885
US-20120189347-A1 CHARGE TRANSPORT MOLECULES AND METHOD FOR PREPARING SAME SLC43A1, HRH3, H1-4 ALDH1A1 1657/4885TSHR 201/4885CYP3A4 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.